G C A T T A C G G C A T genes Review ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises Judith C. Birkhoff 1, Danny Huylebroeck 1,2 and Andrea Conidi 1,* 1 Department of Cell Biology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands;
[email protected] (J.C.B.);
[email protected] (D.H.) 2 Department of Development and Regeneration, Unit Stem Cell and Developmental Biology, Biomedical Sciences Group, KU Leuven, 3000 Leuven, Belgium * Correspondence:
[email protected]; Tel.: +31-10-7043169; Fax: +31-10-7044743 Abstract: After its publication in 1999 as a DNA-binding and SMAD-binding transcription factor (TF) that co-determines cell fate in amphibian embryos, ZEB2 was from 2003 studied by embryologists mainly by documenting the consequences of conditional, cell-type specific Zeb2 knockout (cKO) in mice. In between, it was further identified as causal gene causing Mowat-Wilson Syndrome (MOWS) and novel regulator of epithelial–mesenchymal transition (EMT). ZEB2’s functions and action mechanisms in mouse embryos were first addressed in its main sites of expression, with focus on those that helped to explain neurodevelopmental and neural crest defects seen in MOWS patients. By doing so, ZEB2 was identified in the forebrain as the first TF that determined timing of neuro- /gliogenesis, and thereby also the extent of different layers of the cortex, in a cell non-autonomous fashion, i.e., by its cell-intrinsic control within neurons of neuron-to-progenitor paracrine signaling. Transcriptomics-based phenotyping of Zeb2 mutant mouse cells have identified large sets of intact- ZEB2 dependent genes, and the cKO approaches also moved to post-natal brain development Citation: Birkhoff, J.C.; Huylebroeck, and diverse other systems in adult mice, including hematopoiesis and various cell types of the D.; Conidi, A.